Skip to main content
13 April 2021
Last updated:
Tuesday 13 April 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

René Goedkoop becomes acting CMO at Medigene

Sunday 28 March 2021
Company
Medigene AG
Appointee Name
René Goedkoop 
Goedkoop
Country

Germany

René Goedkoop has become acting chief medical officer at Medigene AG, a German biotech, following the departure, for personal reasons, of Kai Pinkernell. Dr Pinkernell will continue in an advisory capacity for six months. Dr Goedkoop has been vice president of clinical affairs at Medigene since January 2019.

In his new role as acting CMO, he will be responsible for overseeing clinical projects including the ongoing trial of a T cell receptor modified T cell therapy for cancer. Dr Goedkoop previously held CMO positions at Sensimed SA of Switzerland; EryDel SpA of Italy; and Pharnext SA of France.

Medigene announced change in management on 18 March 2021.

Copyright 2021 Evernow Publishing Ltd

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

René Hoet becomes CSO at Montis Biosciences
Wednesday March 31 2021
Pan Cancer T makes board appointments
Wednesday March 31 2021
Björn Englund appointed CEO at Opterion
Wednesday March 31 2021
Sven Zimmermann joins Inotrem
Wednesday March 31 2021
New director at Mission Therapeutics
Wednesday March 31 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.